Conversion from delayed-release sodium valproate to extended-release sodium valproate in a moderately mentally retarted pediatric population

被引：0
|
作者：
Scully, Audrey [1 ]
Conry, Joan A. [1 ]
Kolodgie, Marian J. [1 ]
Renuart, Andrew [1 ]
Sigman, Michael [1 ]
Salpekar, Jay [1 ]
机构：
[1] Childrens Natl Med Ctr, Washington, DC 20010 USA
来源：
EPILEPSIA | 2006年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [1] Conversion from delayed-release sodium valproate to extended-release sodium valproate: Initial results and long-term follow-up
    McCabe, PH
    Michel, NC
    Mcnew, CD
    Lehman, EB
    [J]. EPILEPSY & BEHAVIOR, 2006, 8 (03) : 601 - 605
  • [2] Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium
    Longo, LP
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (08): : 1548 - 1549
  • [3] Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium
    Horne, RL
    Cunanan, C
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (02) : 176 - 181
  • [4] Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets - Clinical implications
    Dutta, S
    Reed, RC
    O'Dea, RF
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (04) : 619 - 625
  • [5] Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit
    Boggs, JG
    Preis, T
    [J]. EPILEPSIA, 2005, 46 (06) : 949 - 951
  • [6] Effectiveness and safety of an extended-release tablet of sodium valproate for the prophylactic treatment of migraine: Postmarketing surveillance in Japan
    Takeshima, Takao
    Suzuki, Norihiro
    Matsumori, Yasuhiko
    Shimmoto, Naoki
    Kurihara, Yuji
    Gunji, Ryoji
    Sakai, Fumihiko
    [J]. NEUROLOGY AND CLINICAL NEUROSCIENCE, 2016, 4 (04): : 134 - 141
  • [7] Comparative absorption profiles of divalproex sodium delayed-release vs. extended-release tablets-clinical implications
    Dutta, S
    Reed, RC
    O Dea, R
    [J]. NEUROLOGY, 2005, 64 (06) : A189 - A190
  • [8] Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers
    Dutta, S
    Zhang, YM
    Selness, DS
    Lee, LL
    Williams, LA
    Sommerville, KW
    [J]. EPILEPSY RESEARCH, 2002, 49 (01) : 1 - 10
  • [9] Adjunct extended-release valproate semisodium in late life schizophrenia
    Saiatovic, Martha
    Coconcea, Nicoleta
    Ignacio, Rosalinda V.
    Blow, Frederic C.
    Hays, Robert W.
    Cassidy, Kristin A.
    Meyer, William J.
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (02) : 142 - 147
  • [10] Favorable response of ADHD with giant SEP to extended-release valproate
    Miyazaki, Masahito
    Ito, Hiromichi
    Saijo, Takahiko
    Mori, Kenji
    Kagami, Shoji
    Kuroda, Yasuhiro
    [J]. BRAIN & DEVELOPMENT, 2006, 28 (07): : 470 - 472
12345